🩸 Rare Blood Types ⏱ 9 min read 📅 Updated: July 2026

Rare Rhesus Phenotypes and Their Significance

In This Article

Common Rhesus phenotypes are well understood, but rare variants present real challenges in transfusion medicine. Occurring in fewer than 1 in 1000 individuals, they can complicate blood matching and call for specialised management.

⚠️ Critical Alert for Rare Phenotypes

Rhnull: The Golden Blood

The Rarest Known Blood Type

Rhnull individuals lack ALL Rh antigens on their red blood cells, earning the designation "golden blood." With fewer than 50 known cases worldwide, this is the rarest blood type known to medical science.

For a comprehensive deep-dive into Rh null, including detailed genetics, transfusion protocols, and patient management, see our dedicated article: Rh Null: The Golden Blood.

Genetic Basis

Rhnull phenotype results from two distinct genetic mechanisms:

Types of Rhnull

Regulator Type: Mutations in the RHAG gene (most common)

Amorph Type: Deletions or mutations in both RHD and RHCE genes

Clinical Features

Clinical Aspect Manifestation Management
Haemolytic Anaemia Mild to moderate, compensated Usually no treatment needed
Red Cell Morphology Stomatocytosis, spherocytosis Monitor blood counts
Osmotic Fragility Increased Avoid dehydration
Transfusion Risk Can form anti-RH29 (anti-total Rh) Only Rhnull blood compatible

D-- Phenotype: Missing C, c, E, and e

The D-- phenotype (pronounced "D dash dash") expresses only the D antigen, lacking C, c, E, and e antigens. This results from deletion mutations or hybrid genes that disrupt normal RHCE expression.

D-- Characteristics

Frequency: Approximately 1 in 100,000 or less in most populations

Expresses very strong D antigen but lacks all RHCE antigens. Can develop anti-Rh17 (anti-Hr0) antibody.

  • Found across multiple ethnic backgrounds including African, Japanese, and Caucasian populations
  • Often runs in families (autosomal recessive mechanism)
  • Requires D-- or Rhnull blood

Dc- Phenotype

Frequency: Rare (population-specific)

Lacks E and e antigens. Can form anti-Rh18 (anti-Hr) antibody reacting with all e+ cells.

  • Found in various ethnic groups
  • Less restrictive than D--
  • Compatible donors easier to find

D-E Phenotype

Frequency: Extremely rare

Lacks C and c antigens. Can develop antibodies to high-frequency antigens.

  • Very few cases reported
  • Complex antibody patterns
  • Challenging transfusion support

Clinical Implications

Transfusion Challenges

Individuals with D-- phenotype face severe transfusion limitations:

Partial D: Implications for Transfusion and Pregnancy

Partial D variants have qualitative changes in the D antigen, missing some epitopes while expressing others. Unlike weak D, which has reduced but complete D antigen, partial D individuals can develop anti-D against the missing epitopes.

Partial D Type Population Missing Epitopes Clinical Significance
DVI Caucasian epD 1, 2, 5, 6/7, 9 Most clinically important; can make anti-D
DIII African epD 4, 5, 9 Common in African populations
DIVa African epD 2, 5 May be missed by some reagents
DV African epD 5 Variable expression patterns

Management Strategies

Clinical Management Protocol for Partial D

  1. As Transfusion Recipients: Treat as D-negative
    • Provide D-negative blood
    • Prevents anti-D formation
  2. As Blood Donors: Label as D-positive
    • Can immunise D-negative recipients
    • Safe for D-positive recipients
  3. During Pregnancy: Case-by-case assessment
    • DVI women: Give RhIg prophylaxis
    • Other types: Molecular testing recommended
    • Monitor for anti-D development
  4. Antibody Screening: Enhanced protocols
    • Use panels including partial D cells
    • Consider molecular characterisation

Weak D Types: A Spectrum of Expression

Weak D encompasses numerous genetic variants causing reduced D antigen expression. Types 1, 2, and 3 account for 90% of Caucasian weak D cases and are not at risk for anti-D formation.

Weak D Classification

Types 1, 2, 3: Safe to treat as D-positive

Type 4 variants (4.0, 4.1, 4.2): Variable management

Other types: Individual assessment needed

Weak D variants (previously misclassified):

Testing Challenges

Laboratory Considerations

Managing Rare Phenotypes

Successful management of patients with rare phenotypes requires coordinated approaches involving multiple strategies:

Comprehensive Management Approach

International Rare Donor Programs

Program/Registry Coverage Services
International Rare Donor Panel Global Coordinates between 25+ countries
American Rare Donor Program USA Database of >50,000 rare donors
UK Rare Donor Panel United Kingdom NHS-coordinated registry
Japanese Rare Donor Registry Japan Focus on Asian-specific variants
ISBT Working Party International Standardisation and coordination

Emergency Management Protocols

Emergency Transfusion for Rare Phenotypes

  1. Immediate actions:
    • Contact reference laboratory
    • Search rare donor registries
    • Screen family members urgently
  2. If no compatible blood available and life-threatening bleeding:
    • Use least incompatible units (only when no alternative exists)
    • Consider plasma exchange first
    • Minimise transfusion volume
    • Monitor closely for reactions
  3. Support measures:
    • Optimise oxygen carrying capacity
    • Consider erythropoietin
    • Aggressive iron supplementation

Pregnancy Management

Women with rare phenotypes require specialised prenatal care:

Prenatal Management Strategy

First Trimester:

Second Trimester:

Third Trimester:

The Role of Reference Laboratories

Reference laboratories are central to managing rare phenotypes, providing specialised testing and coordination:

Specialised Testing

  • Advanced serological techniques
  • Molecular genotyping
  • Antibody identification
  • Family studies
  • Phenotype confirmation

Registry Management

  • Maintain rare donor databases
  • Coordinate international searches
  • Facilitate donor-recipient matching
  • Track rare unit inventory
  • Emergency response coordination

Consultation Services

  • Clinical management guidance
  • Transfusion recommendations
  • Prenatal counseling
  • Educational resources
  • Research collaboration

Advanced Testing Capabilities

Test Type Application Typical Turnaround Time
Extended phenotyping Complete antigen profile 1-2 days
Adsorption/elution Complex antibody identification 2-3 days
Molecular genotyping Definitive variant identification 3-7 days
Whole genome sequencing Novel variant discovery 2-4 weeks
Flow cytometry Antigen density measurement 1-2 days

Case Study Examples

Case 1: Rhnull Patient Requiring Surgery

Situation: 45-year-old Rhnull patient needs cardiac surgery

Challenge: No compatible donors in country

Solution:

Case 2: D-- Mother with Anti-Rh17

Situation: Second pregnancy, high-titre anti-Rh17

Management:

Future Perspectives

Emerging Technologies for Rare Blood Management

In Vitro Red Cell Production:

Gene Editing:

Artificial Blood Substitutes:

Key Takeaways

Rare Rhesus phenotypes are demanding to manage and often depend on international cooperation to find compatible blood. Family screening, autologous donation, cryopreservation, and rare donor registries are the main tools, and molecular methods increasingly underpin accurate diagnosis.

Healthcare providers who encounter unusual serological patterns should suspect a rare variant and consult a reference laboratory early. Identifying these patients before a transfusion is urgently needed gives the best chance of sourcing compatible units in time.

↑ Back to Top

References

  1. Daniels G. Human Blood Groups. 3rd ed. Oxford: Wiley-Blackwell; 2013.
  2. Vos GH, Vos D, Kirk RL, Sanger R. A sample of blood with no detectable Rh antigens. Lancet. 1961;1(7173):14–15.
  3. Huang CH, Liu PZ, Cheng JG. Molecular biology and genetics of the Rh blood group system. Semin Hematol. 2000;37(2):150–165.
  4. Westhoff CM. The structure and function of the Rh antigen complex. Semin Hematol. 2007;44(1):42–50.
  5. Flegel WA. Molecular genetics and clinical applications for RH. Transfus Apheresis Sci. 2011;44(1):81–91.
  6. Klein HG, Anstee DJ. Mollison’s Blood Transfusion in Clinical Medicine. 12th ed. Oxford: Wiley-Blackwell; 2014.

Continue Learning

Understanding Rhesus Blood Groups

Master the basics of the Rh system and common phenotypes.

Molecular vs. Serological Testing

Learn how different testing methods identify rare variants.

Rh Null: The Golden Blood

Deep dive into the world's rarest blood type and its clinical management.